Identification of biomarkers for physical frailty and sarcopenia through a new multi-marker approach: results from the BIOSPHERE study
- PMID: 32488674
- PMCID: PMC8110636
- DOI: 10.1007/s11357-020-00197-x
Identification of biomarkers for physical frailty and sarcopenia through a new multi-marker approach: results from the BIOSPHERE study
Abstract
Physical frailty and sarcopenia (PF&S) is a prototypical geriatric condition characterized by reduced physical function and low muscle mass. The aim of the present study was to provide an initial selection of biomarkers for PF&S using a novel multivariate analytic strategy. Two-hundred community-dwellers, 100 with PF&S and 100 non-physically frail, non-sarcopenic (nonPF&S) controls aged 70 and older were enrolled as part of the BIOmarkers associated with Sarcopenia and Physical frailty in EldeRly pErsons (BIOSPHERE) study. A panel of 74 serum analytes involved in inflammation, muscle growth and remodeling, neuromuscular junction damage, and amino acid metabolism was assayed. Biomarker selection was accomplished through sequential and orthogonalized covariance selection (SO-CovSel) analysis. Separate SO-CovSel models were constructed for the whole study population and for the two genders. The model with the best prediction ability obtained with the smallest number of variables was built using seven biomolecules. This model allowed correct classification of 80.6 ± 5.3% PF&S participants and 79.9 ± 5.1% nonPF&S controls. The PF&S biomarker profile was characterized by higher serum levels of asparagine, aspartic acid, and citrulline. Higher serum concentrations of platelet-derived growth factor BB, heat shock protein 72 (Hsp72), myeloperoxidase, and α-aminobutyric acid defined the profile of nonPF&S participants. Gender-specific SO-CovSel models identified a "core" biomarker profile of PF&S, characterized by higher serum levels of aspartic acid and Hsp72 and lower concentrations of macrophage inflammatory protein 1β, with peculiar signatures in men and women.SO-CovSel analysis allowed identifying a set of potential biomarkers for PF&S. The adoption of such an innovative multivariate approach could help address the complex pathophysiology of PF&S, translate biomarker discovery from bench to bedside, and unveil novel targets for interventions.
Keywords: Amino acids; Cytokines; Geroscience; Inflammation; Multivariate; Muscle.
Conflict of interest statement
A.P., E.M., F.L., M.C., and R.C. are partners of the SPRINTT consortium, which is partly funded by the European Federation of Pharmaceutical Industries and Associations (EFPIA).
E.M. served as a consultant for Abbott, Biophytis, Nutricia, and Nestlè. R.C. served as a consultant for Abbott and Nutricia. M.C. served as a consultant for and/or received honoraria for scientific presentations from Nestlé and received a research grant from Pfizer.
Figures
Similar articles
-
Inflammatory signatures in older persons with physical frailty and sarcopenia: The frailty "cytokinome" at its core.Exp Gerontol. 2019 Jul 15;122:129-138. doi: 10.1016/j.exger.2019.04.019. Epub 2019 May 2. Exp Gerontol. 2019. PMID: 31054959
-
Gut Microbial, Inflammatory and Metabolic Signatures in Older People with Physical Frailty and Sarcopenia: Results from the BIOSPHERE Study.Nutrients. 2019 Dec 26;12(1):65. doi: 10.3390/nu12010065. Nutrients. 2019. PMID: 31887978 Free PMC article.
-
A Distinct Pattern of Circulating Amino Acids Characterizes Older Persons with Physical Frailty and Sarcopenia: Results from the BIOSPHERE Study.Nutrients. 2018 Nov 6;10(11):1691. doi: 10.3390/nu10111691. Nutrients. 2018. PMID: 30404172 Free PMC article.
-
Biomarkers shared by frailty and sarcopenia in older adults: A systematic review and meta-analysis.Ageing Res Rev. 2022 Jan;73:101530. doi: 10.1016/j.arr.2021.101530. Epub 2021 Nov 25. Ageing Res Rev. 2022. PMID: 34839041 Review.
-
Biomarkers of Physical Frailty and Sarcopenia: Coming up to the Place?Int J Mol Sci. 2020 Aug 6;21(16):5635. doi: 10.3390/ijms21165635. Int J Mol Sci. 2020. PMID: 32781619 Free PMC article. Review.
Cited by
-
miRNome Profiling Detects miR-101-3p and miR-142-5p as Putative Blood Biomarkers of Frailty Syndrome.Genes (Basel). 2022 Jan 26;13(2):231. doi: 10.3390/genes13020231. Genes (Basel). 2022. PMID: 35205276 Free PMC article.
-
Diagnostic Value of Inflammatory Markers in Elderly Arab Women with Sarcopenia.Diagnostics (Basel). 2022 Sep 23;12(10):2293. doi: 10.3390/diagnostics12102293. Diagnostics (Basel). 2022. PMID: 36291982 Free PMC article.
-
A Multifactorial Approach for Sarcopenia Assessment: A Literature Review.Biology (Basel). 2021 Dec 20;10(12):1354. doi: 10.3390/biology10121354. Biology (Basel). 2021. PMID: 34943268 Free PMC article. Review.
-
Circulating Inflammatory, Mitochondrial Dysfunction, and Senescence-Related Markers in Older Adults with Physical Frailty and Sarcopenia: A BIOSPHERE Exploratory Study.Int J Mol Sci. 2022 Nov 13;23(22):14006. doi: 10.3390/ijms232214006. Int J Mol Sci. 2022. PMID: 36430485 Free PMC article.
-
Diagnostic Criteria and Measurement Techniques of Sarcopenia: A Critical Evaluation of the Up-to-Date Evidence.Nutrients. 2024 Feb 1;16(3):436. doi: 10.3390/nu16030436. Nutrients. 2024. PMID: 38337720 Free PMC article. Review.
References
-
- Berghella AM, Contasta I, Marulli G, D’Innocenzo C, Garofalo F, Gizzi F, Bartolomucci M, Laglia G, Valeri M, Gizzi M, Friscioni M, Barone M, del Beato T, Secinaro E, Pellegrini P. Ageing gender-specific “Biomarkers of Homeostasis”, to protect ourselves against the diseases of the old age. Immun Ageing. 2014;11:3. doi: 10.1186/1742-4933-11-3. - DOI - PMC - PubMed
-
- Biancolillo A, Måge I, Næs T. Combining SO-PLS and linear discriminant analysis for multi-block classification. Chemom Intell Lab Syst. 2015;141:58–67. doi: 10.1016/J.CHEMOLAB.2014.12.001. - DOI
-
- Biancolillo A, Marini F, Roger JM. SO-CovSel: a novel method for variable selection in a multi-block framework. J Chemom. 2020;34:e3120. doi: 10.1002/cem.3120. - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials